Concord Biotech Ltd.

Market Capital
₹11,279 Cr.
P/E
46.98
Share Price
₹ 1055.6 -20.25 (-1.88%)

Concord Biotech Ltd.

Quick View
₹ 1055.6 -20.25 (-1.88%)
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Forensics
ROE
ROE has decreased vs 10 year trend
Other Income
Other Income is not affecting ratios of the company
Capex vs ROCE
Company has made significant capex which might be affecting its ROCE
Pledge
insufficient data
Working Capital
Company has significant working capital which is dragging its ROCE and ROE
Revenue Recognition
Company is converting accounting profit to cash
Depreciation Effect
Depreciation accounting is not leading to increase in profits
Contingent Liabilities
Company does not have significant contingent liabilities
Retail Holding
insufficient data
Share price
insufficient data
Current vs Historic Valuation
insufficient data
Promoter Holding
Promoter has not sold any shares in the last 90 days
Debt
Company should not have issues servicing its debt
ROE
Latest
18.61%
3yr Average
19.32%
5yr Average
19.45%
Net Profit Margin
Latest
28.14%
3yr Average
30.25%
5yr Average
30.18%
ROCE
Latest
24.95%
3yr Average
25.16%
5yr Average
25.37%
Debt to Equity
Latest
0.02
3yr Average
0.06
5yr Average
0.05
Market Share
20% (as of Mar 22)
Fermentation Based API Products - Market Share
Show more
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Asset Break-Up

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    locked
    Select a Metric
    • US DMF Filings (No)
      Source
    • Europe DMF Filings (No)
      Source
    • Global DMFs filed (No)
      Source
    • Total reactor capacity (kL)
      Source
    • Japan DMF Filings (No)
      Source
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Company Filing
    Show Previous Years
    Discussions & Analysis
    timeline
    Sign Up for Free